EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A defective splicing machinery promotes senescence through MDM4 alternative splicing

Mathieu Deschênes, Mathieu Durand, Marc-Alexandre Olivier, Alicia Pellerin-Viger, Francis Rodier iD, Benoit Chabot iD

Aging Cell · 2024

DOI: 10.1111/acel.14301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2024. Verfasst von Mathieu Deschênes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins, Alternative Splicing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defects in the splicing machinery are implicated in various diseases, including cancer. We observed a general reduction in the expression of spliceosome components and splicing regulators in human cell lines undergoing replicative, stress‐induced, and telomere uncapping‐induced senescence. Supporting the view that defective splicing contributes to senescence, splicing inhibitors herboxidiene, and pladienolide B induced senescence in normal and cancer cell lines. Furthermore, depleting individual spliceosome components also promoted senescence. All senescence types were associated with an alternative splicing transition from the MDM4‐FL variant to MDM4‐S . The MDM4 splicing shift was reproduced when splicing was inhibited, and spliceosome components were depleted. While decreasing the level of endogenous MDM4 promoted senescence and cell survival independently of the MDM4‐S expression status, cell survival was also improved by increasing MDM4‐S . Overall, our work establishes that splicing defects modulate the alternative splicing of MDM4 to promote senescence and cell survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene ProteinsAlternative SplicingRNA SplicingCell SurvivalRNA Splicing FactorsDown-RegulationSpliceosomesFatty AlcoholsEpoxy CompoundsCell Line, TumorHumansCell Cycle ProteinsPyransMacrolides

Stichwörter der Autor:innen

MDM4RNAalternative splicingsenescencespliceosomesplicing factors

Substanzen

Proto-Oncogene ProteinsRNA Splicing FactorsFatty AlcoholsEpoxy CompoundsMDM4 protein, humanCell Cycle ProteinsherboxidienePyranspladienolide BMacrolides

Autor:innen und Institutionen

  • Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
  • Institut du Cancer de Montréal, Montréal, Quebec, Canada.
  • Department of Radiology, Radio-Oncology and Nuclear Medicine, Université de Montréal, Montréal, Quebec, Canada.

ORCID-Profile: Francis Rodier, Benoit Chabot

Förderung

  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Deschênes, M., Durand, M., Olivier, M. A., Pellerin-Viger, A., Rodier, F., & Chabot, B. (2024). A defective splicing machinery promotes senescence through MDM4 alternative splicing. Aging Cell. https://doi.org/10.1111/acel.14301

Vancouver

Deschênes M, Durand M, Olivier MA, Pellerin-Viger A, Rodier F, Chabot B. A defective splicing machinery promotes senescence through MDM4 alternative splicing. Aging Cell. 2024. doi:10.1111/acel.14301

BibTeX
@article{Deschnes2024,
  author = {Deschênes, Mathieu and Durand, Mathieu and Olivier, Marc-Alexandre and Pellerin-Viger, Alicia and Rodier, Francis and Chabot, Benoit},
  title = {A defective splicing machinery promotes senescence through MDM4 alternative splicing},
  journal = {Aging Cell},
  year = {2024},
  doi = {10.1111/acel.14301}
}
Kostenlos starten →